by tatyana borovskaya laboratory of pharmacology of reproductive system the goldberg research...

22
by Tatyana Borovskaya Laboratory of Pharmacology of Reproductive System The Goldberg Research Institute of Pharmacology, Tomsk, RUSSIA Reproductive toxicity of cyto- Reproductive toxicity of cyto- static drugs and static drugs and pharmacological ways to reduce pharmacological ways to reduce it it

Upload: beverley-kelly

Post on 18-Dec-2015

225 views

Category:

Documents


1 download

TRANSCRIPT

by Tatyana Borovskaya

Laboratory of Pharmacology of Reproductive SystemThe Goldberg Research Institute of Pharmacology, Tomsk, RUSSIA

Reproductive toxicity of cyto-static Reproductive toxicity of cyto-static drugs and pharmacological ways to drugs and pharmacological ways to

reduce itreduce it

Intensity of reproductive dysfunction in women with cancer under different treatment regimens

Does not result in sterilizationPOMB/ACEOvarian cancer (after conserving surgery)

amenorrhea

amenorrhea in the majority of

amenorrhea women

Violations in ovarian cycle are minimal

COPP

EEACOPP

CHOP

ABVD

Hemoblastosis

amenorrhea in 88%

amenorrhea in 55%

СМF

FACBreast Cancer

Status of reproductive

functionSchemeDisease

*Berthon L. (1987). Traitements anticancereux et fertilite. J. France Medicine, 94:247-8.

*Mormor D. (1993). Fertile après traitements cytostatiques. Contracept.-fertil.-sex., 21(10):739-43.

*Evain P.L. Bazonzelly M., Dusol F., Demaille M. (1986). Chemiotherapia anticancereuse at fertilite cher la femime. Rev. Fr. gynecolog at obsted., 3:451-4.

*Howell S.G., Shalet S.M. (2001). Testicular function following chemoterapy. Human Reprod. Update, 7 (4):3369-3.

*Taksey Y, dissada N.K., Chayndhary U.B. (2003). Fertility after chemotherapy for testicular cancer. Arch. Androl., 49(5):389-95.

Group and name of the drug,Group and name of the drug,chemical structurechemical structure

Main mechanism of anti-tumor actionMain mechanism of anti-tumor action

PLATINUM COMPLEXES

Сisplatin, Сisplatin, Lachema ACLachema AC, , AustriaAustriaForm a cross-link between DNA moleculesForm a cross-link between DNA molecules

Carboplatin, Carboplatin, EBEWE PharmaEBEWE Pharma, , AustriaAustria

ANTHRACYCLINE ANTIBIOTICS

Doxorubicin, Doxorubicin, EBEWE PharmaEBEWE Pharma, , AustriaAustriaIntercalation between the base pairs of Intercalation between the base pairs of DNADNA

Epirubicin, Epirubicin, Karlo ArbaKarlo Arba, Italy, Italy

INHIBITORS TOPOIZOMERAZNOY ACTIVITY

Еtoposide, Еtoposide, Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries, , IsraelIsrael IInhibition of topoisomerase nhibition of topoisomerase IIII

TAXOIDS

Paclitaxel, Paclitaxel, Dr ReddisDr Reddis, I, Indiandia Stimulation of assembling of anomalous Stimulation of assembling of anomalous microtubules microtubules

The object of study is Wistar rats

Research terms

The assessment of effects was performed 3 and 6 months after administration of cyto-static drugs

The drugs were administered intravenously in a single MTD, because in clinics high-dose therapy is used

Methods of study

•• morphological (using quantitative indicators characterizing extent of the damage)• • functional(fertility index, the index pregnancy, fetal death)

gonads testes

Early antiproliferative effects of cytotoxic drugs on gonads

On testicular tissue:

Tubules with the 12th stage of meiosis, %

Number of normal spermatogonia, % of control

БA

"DNA-comets" of mouse testis

On ovarian tissue::

Death of follicular epithelium cells

0 30 60 90 120 150 1800

300

600

900

1200

Primordial follicles

А – cells with DNA-damages

B – Apotopic "DNA-comets"

Control Epirubicin Etoposide Doxorubicin Cisplatin Paclitaxel

B

Content of structural-functional elements of rats ovaries, 6 months after a single injection of anticancer drugs in the MTD (% of control)

Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

Ep Cs Cr Et P Ep Cs Cr Et P Ep Cs Cr Et P

Primordial follicles Double or multiple follicles Graafian follicles Total number of generative

elements

Intensity of long-term-late effects of cyto-static drugs on structural and functional elements of the rat ovary is decreased

in the following order:

Epirubicin

Etoposide

Paclitaxel

Cisplatin

Carboplatin

Efficiency of mating in female-rats in the long-term period after administration of cytotoxic drugs of different groups

Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

0

20

40

60

80

100

Percentage of control

Ep Cs Cr Et P

Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

0

20

40

60

80

100

Preimplantation mortality Postimplantation mortality

Ep Cs Cr Et PEp Cs Cr Et P

Embryonic mortality in female rats while the crossbreeding long-term period after administration of cito-static drugs of different groups

(% of control)

*

* ** *

Toxic effect of drugs on embryonic mortality is decreased in the following order:

Taxanes

Inhibitors of topo-isomerase

activity

Anthracycline antibiotics Platinoids

Intact rat testis, age 5.5 months, x160. Staining with hematoxylin and eosin.

Testis rats 3 months after administration of Paclitaxel and / or Epirubicin, x160.

Thinning seminiferous epithelium. Staining with hematoxylin and eosin.

Morphological status of the testes of rats at 3 months after administration

of Paclitaxel and Epirubicin

0

20

40

60

80

100

120

Total sperm count, million Efficiency of mating, % ofcontrol

Ep Cr Cs Et P Ep Cr Cs Et P

*

* *

*

Sperm count, and efficiency of mating male rats at 3 months after administration of cyto-static drugs of different groups

Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

State of reproductive system of male rats long-term after administration of cyto-static drugs of different groups

DrugDrug SSexual instinctexual instinct FertilityFertility

Level ofLevel of  (DLM)(DLM)(characterizes the (characterizes the probability to save probability to save

pregnancy)pregnancy)

Platidiam Not disturbed Not disturbed Not increased

Сarboplatin Not disturbed Not disturbed Not increased

Pharmorubicin Not disturbed Infertility, 100 % Not increased

Doxorubicin Not disturbed Not disturbed Not increased

Etoposide Not disturbed Not disturbed Increased

Paclitaxel Not disturbed Infertility, 100 % Increased

Toxicity decreases in the following order:

Pharmorubicin Paclitaxel Etoposide

In platinum drugs toxicity was not found

Testis tissue biopsy Cryopreservation of sperm

Cryopreservation of ovarian tissue Cryopreservation of

embryos

Cryopreservation of oocytes

Differentiation of bone marrow stem cells into male germ cells

Negative aspects of assisted reproductive technologies:1. High cost2. Inability to perform due to the need to start chemotherapy3. high sensitivity of oocytes to freezing

Possible ways to reduce the long-term consequences of the effect of cyto-static drugs on reproductive system by assisting

reproductive technologies

IVFISI

Comments:IVF - in vitro fertilizationISI - Intracytoplasmic Sperm InjectionчССК - human spermatogonial stem cell

Stimulator of spermatogenesis (testosterone)

Gonadal-hormone products

Hypothalamic regulators of pituitary function

[Carmely A., 2009]

[Kolomietz О.L. et al., 2001;Borovskaya Т.G. et al., 2003]

.

Эффективность низкая [Delis J. et al., 1987]

[Bоcker L. et al., 1990; Borovskaya Т.G. et al., 2007]

Low efficiency

Widely used in clinic, highlyeffective

[Tilly J.L. et al., 2004]

Immunomodulators

Drugslimiting apoptosis in oocytes (sfignozin monophosphate)

Means of regenerative medicine

[Borovskya Т.G., Dygai А.М., Zhdanov V.V., 2008]

Antioxidants

The effectiveness of drug therapy as the way to reduce the effects of cyto-static gonadotoxicity

Negative aspects:1.High cost2.Inability to perform due to the need to start chemotherapy

Number of structural and functional elements of rats ovaries, 6 months after combined administration

of Etoposide and Buserelin

% of control (etoposide)

Primordial follicles

Double and multiple follicles

Atretic follicle Yellow body

Graafian follicles

Recent years, the new information about the properties of

pluripotent progenitor cells of the body was obtained. The

possibility of mobilizing the internal mechanisms of "deep reserve"

– bone marrow stem cells and their following homing into the

damaged tissue and activation of regional stem cells by various

cytokines is shown.

А.М. А.М. DygaiDygai, , VV..VV. . ZhdanovZhdanov et al.et al. 2006, 2010, 20112006, 2010, 2011

mature seed tubule

immature seed tubule

stem spermatogonia

cell microenvironment - Sertoli cells

Reparative regeneration of testicular tissue after administration of Paclitaxel

Rete testis

Restoring of spermatogonia goes under upgrading of spermatogenic layer

4,5

5

5,5

6

6,5

2 months 3 months0

20

40

60

80

100

2 months 3 months

Amount of spermatogonia (% of background)

0

50

100

150

200

250

2 months 3 months

Total amount of germ cells (% of background)

Degree of maturity of spermatogenic layer (a.u.)

Status of spermatogenesis in rats late after combined administration of paclitaxel with G-CSF and pegylated G-CSF

background

Paclitaxel (control)

Paclitaxel + G-CSF

Paclitaxel + pegylated G-CSF

– differences are significant compared to the background – differences are significant compared to the control

0

50

100

150

200

250

300

350

400

450

% of control

methyimetasulfonate

methyimetasulfonate+antioxidant

Paclitaxel

Paclitaxel+antioxidant

– differences are significant compared to the background

– differences are significant compared to corresponding control

Effect of antioxidant from the group of sterically hindered phenols to the level of DNA comets in the testes of mice treated with

methyl-meta-sulphonate or paclitaxel

Thank you for

attention!